Hudson Bay Capital Management LP Regenxbio Inc. Transaction History

Hudson Bay Capital Management LP

$28.9 Billion
Q1 2025

A detailed history of Hudson Bay Capital Management LP transactions in Regenxbio Inc. stock. As of the latest transaction made, Hudson Bay Capital Management LP holds 295,000 shares of RGNX stock, worth $2.52 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

295,000

Previous 308,100 4.25%

Holding current value

$2.52 Million

Previous $2.38 Million 11.42%

% of portfolio

0.01%

Previous 0.01%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 14, 2025	SELL	$5.92 - $8.7 $77,552 - $113,969	-13,100 Reduced 4.25%	295,000 $2.11 Million
Q4 2024 Feb 14, 2025	BUY	$7.23 - $11.56 $673,113 - $1.08 Million	93,100 Added 43.3%	308,100 $2.38 Million
Q3 2024 Nov 13, 2024	BUY	$10.49 - $14.39 $524,500 - $719,500	50,000 Added 30.3%	215,000 $2.26 Million
Q2 2024 Aug 14, 2024	BUY	$11.51 - $21.53 $1.38 Million - $2.59 Million	120,100 Added 267.48%	165,000 $1.93 Million
Q1 2024 May 15, 2024	SELL	$12.17 - $24.61 $548,867 - $1.11 Million	-45,100 Reduced 50.11%	44,900 $946,000
Q4 2023 Feb 14, 2024	SELL	$12.89 - $20.82 $322,250 - $520,500	-25,000 Reduced 21.74%	90,000 $1.62 Million
Q3 2023 Nov 14, 2023	BUY	$16.46 - $19.99 $493,800 - $599,700	30,000 Added 35.29%	115,000 $1.89 Million
Q2 2023 Aug 14, 2023	BUY	$17.23 - $21.71 $416,966 - $525,382	24,200 Added 39.8%	85,000 $1.7 Million
Q1 2023 May 15, 2023	BUY	$18.08 - $24.55 $285,664 - $387,890	15,800 Added 35.11%	60,800 $1.15 Million
Q4 2022 Feb 14, 2023	BUY	$20.4 - $24.73 $509,999 - $618,250	25,000 Added 125.0%	45,000 $1.02 Million
Q3 2022 Nov 14, 2022	SELL	$22.29 - $35.04 $1.11 Million - $1.75 Million	-50,000 Reduced 71.43%	20,000 $529,000
Q2 2022 Aug 12, 2022	BUY	$19.35 - $35.04 $96,750 - $175,200	5,000 Added 7.69%	70,000 $1.73 Million
Q4 2021 Feb 14, 2022	BUY	$30.19 - $40.28 $452,850 - $604,200	15,000 Added 30.0%	65,000 $2.13 Million
Q3 2021 Nov 15, 2021	SELL	$29.09 - $45.68 $799,975 - $1.26 Million	-27,500 Reduced 35.48%	50,000 $2.1 Million
Q2 2021 Aug 16, 2021	BUY	$32.46 - $40.48 $1.02 Million - $1.27 Million	31,360 Added 67.97%	77,500 $3.01 Million
Q1 2021 May 14, 2021	BUY	$33.61 - $49.95 $206,365 - $306,693	6,140 Added 15.35%	46,140 $1.57 Million
Q4 2020 Feb 12, 2021	SELL	$26.52 - $49.35 $5.91 Million - $11 Million	-223,000 Reduced 84.79%	40,000 $1.81 Million
Q3 2020 Nov 12, 2020	BUY	$27.01 - $40.26 $1.16 Million - $1.73 Million	43,000 Added 19.55%	263,000 $7.24 Million
Q2 2020 Aug 12, 2020	BUY	$27.75 - $43.44 $2.64 Million - $4.13 Million	95,000 Added 76.0%	220,000 $8.1 Million
Q1 2020 May 14, 2020	SELL	$21.5 - $54.2 $322,500 - $813,000	-15,000 Reduced 10.71%	125,000 $4.05 Million
Q4 2019 Feb 12, 2020	BUY	$34.54 - $44.87 $1.74 Million - $2.26 Million	50,406 Added 56.26%	140,000 $5.74 Million
Q3 2019 Nov 13, 2019	BUY	$31.84 - $50.88 $2.85 Million - $4.56 Million	89,594 New	89,594 $3.19 Million
Q3 2018 Nov 14, 2018	SELL	$65.0 - $82.15 $2.6 Million - $3.29 Million	-40,000 Closed	0 $0
Q2 2018 Aug 13, 2018	SELL	$27.2 - $74.35 $1.36 Million - $3.72 Million	-50,000 Reduced 55.56%	40,000 $2.87 Million
Q1 2018 May 14, 2018	BUY	$24.05 - $37.5 $360,750 - $562,500	15,000 Added 20.0%	90,000 $2.69 Million
Q4 2017 Feb 12, 2018	BUY	$26.0 - $34.6 $1.43 Million - $1.9 Million	55,000 Added 275.0%	75,000 $2.49 Million
Q3 2017 Nov 13, 2017	BUY	$18.0 - $32.95 $360,000 - $659,000	20,000	20,000 $659,000

Others Institutions Holding RGNX

# of Institutions

182

Shares Held

45.4M

Call Options Held

64.9K

Put Options Held

103K

View Full List

About REGENXBIO Inc.

Ticker RGNX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 43,230,000
Market Cap $369M
Description
REGENXBIO Inc., a clinical-stage biotechnology company, provides gene therapy product candidates to deliver genes to cells to address genetic defects or to enable cells in the body to produce therapeutic proteins or antibodies that are intended to impact disease. Its gene therapy product candidates are based on NAV Technology Platform, a proprie...

More about RGNX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Hudson Bay Capital Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Hudson Bay Capital Management LP with notifications on news.

Account

Hudson Bay Capital Management LP Regenxbio Inc. Transaction History